Skip to main content

HomeDSIPLegal status

Educational — Not Legal AdviceReviewed

Is DSIP legal? FDA status and US regulatory standing

Current status

Compounding nomination withdrawn. DSIP was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists.

Primary source: www.fda.gov

Federal legal status

FDA approval status

DSIP was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Endogenous neuropeptide discovered 1977. Studied for sleep disorders but no FDA approval, no NDA or IND. Not on 503A bulks list. Sold as research chemical only.

Also known as

Delta Sleep-Inducing Peptide · Delta Sleep Peptide

Frequently asked questions

Is DSIP FDA approved?
DSIP was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Primary source linked on this page.
Is DSIP legal to buy?
DSIP is available in the U.S. as a research-use-only compound. It was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Sale for human consumption is not permitted.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.